(CNH) CNH Industrial - Overview
Exchange: NYSE •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: NL0010545661
Stock: Farm Machinery, Construction Equipment, Financial Services
Total Rating 41
Risk 78
Buy Signal -0.37
| Risk 5d forecast | |
|---|---|
| Volatility | 36.9% |
| Relative Tail Risk | -5.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.02 |
| Alpha | -20.91 |
| Character TTM | |
|---|---|
| Beta | 1.006 |
| Beta Downside | 1.294 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.75% |
| CAGR/Max DD | -0.22 |
EPS (Earnings per Share)
Revenue
Description: CNH CNH Industrial March 04, 2026
CNH Industrial N.V. designs, produces, markets, sells, and finances agricultural and construction equipment globally. The company operates in North America, Europe, the Middle East, Africa, South America, and the Asia Pacific.
The Agriculture segment manufactures farm machinery, including tractors, harvesters, and planting equipment. This sector is cyclical, influenced by commodity prices and farm income. Key brands include Case IH and New Holland.
The Construction segment produces excavators, loaders, and dozers. This business is also cyclical, driven by infrastructure spending and real estate development. Brands include CASE Construction Equipment and New Holland Construction.
The Financial Services segment offers financing for equipment purchases to end-use customers and dealers, a common business model in capital-intensive industries. This includes wholesale financing and trade receivables factoring under the Banco CNH brand.
For more detailed financial analysis and data points, consider exploring ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 510.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.38 > 1.0 |
| NWC/Revenue: 151.2% < 20% (prev 86.81%; Δ 64.36% < -1%) |
| CFO/TA 0.06 > 3% & CFO 2.54b > Net Income 510.0m |
| Net Debt (23.80b) to EBITDA (2.77b): 8.61 < 3 |
| Current Ratio: 7.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.25b) vs 12m ago -0.48% < -2% |
| Gross Margin: 31.53% > 18% (prev 0.33%; Δ 3121 % > 0.5%) |
| Asset Turnover: 42.24% > 50% (prev 46.20%; Δ -3.96% > 0%) |
| Interest Coverage Ratio: 1.44 > 6 (EBITDA TTM 2.77b / Interest Expense TTM 1.48b) |
Altman Z'' 5.57
| A: 0.64 (Total Current Assets 31.41b - Total Current Liabilities 4.05b) / Total Assets 42.75b |
| B: 0.25 (Retained Earnings 10.51b / Total Assets 42.75b) |
| C: 0.05 (EBIT TTM 2.14b / Avg Total Assets 42.84b) |
| D: 0.22 (Book Value of Equity 7.76b / Total Liabilities 34.92b) |
| Altman-Z'' Score: 5.57 = AAA |
Beneish M -3.01
| DSRI: 1.10 (Receivables 23.53b/23.38b, Revenue 18.09b/19.84b) |
| GMI: 1.04 (GM 31.53% / 32.70%) |
| AQI: 1.01 (AQ_t 0.18 / AQ_t-1 0.17) |
| SGI: 0.91 (Revenue 18.09b / 19.84b) |
| TATA: -0.05 (NI 510.0m - CFO 2.54b) / TA 42.75b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of CNH shares?
As of March 07, 2026, the stock is trading at USD 11.40 with a total of 9,728,605 shares traded.
Over the past week, the price has changed by -6.17%, over one month by -4.44%, over three months by +20.76% and over the past year by -3.22%.
Over the past week, the price has changed by -6.17%, over one month by -4.44%, over three months by +20.76% and over the past year by -3.22%.
Is CNH a buy, sell or hold?
CNH Industrial has received a consensus analysts rating of 4.05.
Therefore, it is recommended to buy CNH.
- StrongBuy: 8
- Buy: 4
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CNH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.2 | 24.1% |
| Analysts Target Price | 14.2 | 24.1% |
CNH Fundamental Data Overview March 06, 2026
P/E Trailing = 29.0244
P/E Forward = 25.7069
P/S = 0.8161
P/B = 1.9774
P/EG = 0.6205
Revenue TTM = 18.09b USD
EBIT TTM = 2.14b USD
EBITDA TTM = 2.77b USD
Long Term Debt = 26.76b USD (from longTermDebt, last quarter)
Short Term Debt = 89.0m USD (from shortTermDebt, last quarter)
Debt = 27.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 23.80b USD (from netDebt column, last quarter)
Enterprise Value = 39.22b USD (14.77b + Debt 27.03b - CCE 2.58b)
Interest Coverage Ratio = 1.44 (Ebit TTM 2.14b / Interest Expense TTM 1.48b)
EV/FCF = 21.84x (Enterprise Value 39.22b / FCF TTM 1.80b)
FCF Yield = 4.58% (FCF TTM 1.80b / Enterprise Value 39.22b)
FCF Margin = 9.93% (FCF TTM 1.80b / Revenue TTM 18.09b)
Net Margin = 2.82% (Net Income TTM 510.0m / Revenue TTM 18.09b)
Gross Margin = 31.53% ((Revenue TTM 18.09b - Cost of Revenue TTM 12.39b) / Revenue TTM)
Gross Margin QoQ = 41.75% (prev 17.62%)
Tobins Q-Ratio = 0.92 (Enterprise Value 39.22b / Total Assets 42.75b)
Interest Expense / Debt = 1.41% (Interest Expense 382.0m / Debt 27.03b)
Taxrate = 40.27% (60.0m / 149.0m)
NOPAT = 1.28b (EBIT 2.14b * (1 - 40.27%))
Current Ratio = 7.75 (Total Current Assets 31.41b / Total Current Liabilities 4.05b)
Debt / Equity = 3.50 (Debt 27.03b / totalStockholderEquity, last quarter 7.73b)
Debt / EBITDA = 8.61 (Net Debt 23.80b / EBITDA 2.77b)
Debt / FCF = 13.25 (Net Debt 23.80b / FCF TTM 1.80b)
Total Stockholder Equity = 7.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.19% (Net Income 510.0m / Total Assets 42.75b)
RoE = 6.58% (Net Income TTM 510.0m / Total Stockholder Equity 7.75b)
RoCE = 6.19% (EBIT 2.14b / Capital Employed (Equity 7.75b + L.T.Debt 26.76b))
RoIC = 3.69% (NOPAT 1.28b / Invested Capital 34.61b)
WACC = 3.82% (E(14.77b)/V(41.80b) * Re(9.26%) + D(27.03b)/V(41.80b) * Rd(1.41%) * (1-Tc(0.40)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.32%
[DCF] Terminal Value 80.82% ; FCFF base≈1.39b ; Y1≈912.7m ; Y5≈416.4m
[DCF] Fair Price = N/A (negative equity: EV 13.27b - Net Debt 23.80b = -10.54b; debt exceeds intrinsic value)
EPS Correlation: -74.18 | EPS CAGR: -9.82% | SUE: 1.94 | # QB: 1
Revenue Correlation: -55.35 | Revenue CAGR: 2.83% | SUE: 3.86 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.11 | Chg7d=+0.002 | Chg30d=-0.026 | Revisions Net=-6 | Analysts=14
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=-0.009 | Chg30d=-0.123 | Revisions Net=-12 | Growth EPS=-24.3% | Growth Revenue=-2.1%
EPS next Year (2027-12-31): EPS=0.75 | Chg7d=-0.021 | Chg30d=-0.075 | Revisions Net=-9 | Growth EPS=+79.3% | Growth Revenue=+7.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 9.3% - Earnings Yield 3.4%)
[Growth] Growth Spread = -7.0% (Analyst -1.2% - Implied 5.8%)
P/E Forward = 25.7069
P/S = 0.8161
P/B = 1.9774
P/EG = 0.6205
Revenue TTM = 18.09b USD
EBIT TTM = 2.14b USD
EBITDA TTM = 2.77b USD
Long Term Debt = 26.76b USD (from longTermDebt, last quarter)
Short Term Debt = 89.0m USD (from shortTermDebt, last quarter)
Debt = 27.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 23.80b USD (from netDebt column, last quarter)
Enterprise Value = 39.22b USD (14.77b + Debt 27.03b - CCE 2.58b)
Interest Coverage Ratio = 1.44 (Ebit TTM 2.14b / Interest Expense TTM 1.48b)
EV/FCF = 21.84x (Enterprise Value 39.22b / FCF TTM 1.80b)
FCF Yield = 4.58% (FCF TTM 1.80b / Enterprise Value 39.22b)
FCF Margin = 9.93% (FCF TTM 1.80b / Revenue TTM 18.09b)
Net Margin = 2.82% (Net Income TTM 510.0m / Revenue TTM 18.09b)
Gross Margin = 31.53% ((Revenue TTM 18.09b - Cost of Revenue TTM 12.39b) / Revenue TTM)
Gross Margin QoQ = 41.75% (prev 17.62%)
Tobins Q-Ratio = 0.92 (Enterprise Value 39.22b / Total Assets 42.75b)
Interest Expense / Debt = 1.41% (Interest Expense 382.0m / Debt 27.03b)
Taxrate = 40.27% (60.0m / 149.0m)
NOPAT = 1.28b (EBIT 2.14b * (1 - 40.27%))
Current Ratio = 7.75 (Total Current Assets 31.41b / Total Current Liabilities 4.05b)
Debt / Equity = 3.50 (Debt 27.03b / totalStockholderEquity, last quarter 7.73b)
Debt / EBITDA = 8.61 (Net Debt 23.80b / EBITDA 2.77b)
Debt / FCF = 13.25 (Net Debt 23.80b / FCF TTM 1.80b)
Total Stockholder Equity = 7.75b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.19% (Net Income 510.0m / Total Assets 42.75b)
RoE = 6.58% (Net Income TTM 510.0m / Total Stockholder Equity 7.75b)
RoCE = 6.19% (EBIT 2.14b / Capital Employed (Equity 7.75b + L.T.Debt 26.76b))
RoIC = 3.69% (NOPAT 1.28b / Invested Capital 34.61b)
WACC = 3.82% (E(14.77b)/V(41.80b) * Re(9.26%) + D(27.03b)/V(41.80b) * Rd(1.41%) * (1-Tc(0.40)))
Discount Rate = 9.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.32%
[DCF] Terminal Value 80.82% ; FCFF base≈1.39b ; Y1≈912.7m ; Y5≈416.4m
[DCF] Fair Price = N/A (negative equity: EV 13.27b - Net Debt 23.80b = -10.54b; debt exceeds intrinsic value)
EPS Correlation: -74.18 | EPS CAGR: -9.82% | SUE: 1.94 | # QB: 1
Revenue Correlation: -55.35 | Revenue CAGR: 2.83% | SUE: 3.86 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.11 | Chg7d=+0.002 | Chg30d=-0.026 | Revisions Net=-6 | Analysts=14
EPS current Year (2026-12-31): EPS=0.42 | Chg7d=-0.009 | Chg30d=-0.123 | Revisions Net=-12 | Growth EPS=-24.3% | Growth Revenue=-2.1%
EPS next Year (2027-12-31): EPS=0.75 | Chg7d=-0.021 | Chg30d=-0.075 | Revisions Net=-9 | Growth EPS=+79.3% | Growth Revenue=+7.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 6 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.8% (Discount Rate 9.3% - Earnings Yield 3.4%)
[Growth] Growth Spread = -7.0% (Analyst -1.2% - Implied 5.8%)